We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

Pfizer (PFE) is a pharmaceutical and biotechnology company valued at $145 billion by market capitalization. While the company ...

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...

Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while ...

Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company’s adjusted EPS of ...

Medicare changes will cut $1 billion from 2025 revenue, with Pfizer now responsible for 20% of catastrophic drug costs. Read ...

Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...

This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, Pfizer is expected to post ...

Stock prices can be irrational in the short term, but tend to follow earnings eventually. Pfizer's high dividend yield may have caught your attention, especially if you're a dividend investor.